Falchook, G., Kurzrock, R., Gouw, L., Hong, D., McGregor, K. A., Zhou, X., . . . Sharma, S. (2014). Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: Phase 1 dose-escalation study. Invest New Drugs.

Falchook, Gerald, Razelle Kurzrock, Launce Gouw, David Hong, Kimberly A. McGregor, Xiaofei Zhou, Hongliang Shi, Howard Fingert, and Sunil Sharma. "Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) As an Enteric-coated Tablet Formulation in Non-hematologic Malignancies: Phase 1 Dose-escalation Study." Invest New Drugs 2014.

Falchook, Gerald, et al. "Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) As an Enteric-coated Tablet Formulation in Non-hematologic Malignancies: Phase 1 Dose-escalation Study." Invest New Drugs 2014.